✦ LIBER ✦

Insulin resistance–associated hepatic iron overload

✍ Scribed by Michel-Henry Mendler; Bruno Turlin; Romain Moirand; Anne-Marie Jouanolle; Thierry Sapey; Dominique Guyader; Jean-Yves le Gall; Pierre Brissot; Véronique David; Yves Deugnier

Book ID: 118521995
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 137 KB
Volume: 117
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(99)70401-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

714 Hypoadiponectinemia is associated wi

714 Hypoadiponectinemia is associated with insulin resistance in patients with non-hfe related hepatic iron overload

✍ A. Salvioni; S. Corbetta; P. Trombini; A. Vergani; S. Coletti; P. Beck-Peccoz; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Efficacy of phlebotomy theraphy and rest

Efficacy of phlebotomy theraphy and restriction caloric intake in patients with insulin resistence-associated hepatic iron overload syndrome (IR-HIO)

✍ Paola Trombini; Anna Vergani; Alessandra Salvioni; Mauro Vigano; Raffaella Maria 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Effects of venesections and restricted d

Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome

✍ Alberto Piperno; Anna Vergani; Alessandra Salvioni; Paola Trombini; Mauro Viganò 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Hepatic iron overload and hepatocellular

Hepatic iron overload and hepatocellular carcinoma

✍ Michael C. Kew 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Hepatic iron accumulation may be associa

Hepatic iron accumulation may be associated with insulin resistance in patients with chronic hepatitis C

✍ Yoshio Sumida; Kazuyuki Kanemasa; Kohei Fukumoto; Naohisa Yoshida; Kyoko Sakai 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

The wide spectrum of hepatic iron overlo

The wide spectrum of hepatic iron overload

✍ Melania Manco; Anna Alisi; Antonella Mosca; Valerio Nobili 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.